Back to mobile site

Leerink Partners Reiterates Outperform Rating on Exact Sciences (EXAS)

October 4, 2024 12:17 PM EDT Send to a Friend
Leerink Partners analyst Puneet Souda reiterated an Outperform rating and $100.00 price target on Exact Sciences (NASDAQ: EXAS).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login